HOME >> BIOLOGY >> NEWS
Inability to pump oxygen during exercise could pinpoint early heart problems

Mildly elevated blood pressure affecting millions of Americans could lead to heart pumping disorders if left untreated. A new Johns Hopkins study indicates that the amount of oxygen that can be circulated throughout the body during each heart beat while exercising could reveal to doctors early signs of heart trouble in this population.

The research, to be presented Oct. 17 at the annual meeting of the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) in Kansas City, should help physicians better follow patients with problems of the left ventricle, or main pumping chamber of the heart, by studying so-called oxygen pulse.

During exercise, lungs take in air and transfer oxygen to the blood, which is then pumped by the heart to the muscles that need it. Oxygen pulse is the amount of oxygen put through this process with each heart beat, and is a measure of cardiovascular efficiency.

Researchers studied 99 adults (44 men and 55 women) ages 55 to 75 who had mild hypertension but were otherwise healthy. The participants' blood pressures ranged from 130 mmHg to 159 mmHg systolic (the upper number) and 85 mmHg to 99 mmHg diastolic (the lower number). These levels are also known as "prehypertension" or "Stage I hypertension."

The Hopkins team measured the adults' heart size and performance at rest through traditional echocardiograms (or ultrasound), and tissue Doppler imaging, a newer ultrasound method that examines the functioning of the heart's walls. Next, they compared those results with the participants' heart performance during exercise while the adults walked on a treadmill. The scientists measured oxygen usage during the exercise portion by having the subject breathe through a mouthpiece attached to a valve that measures how much oxygen is used during the test.

Normally there is a sharp increase in oxygen pulse during the first few minutes of exercise. This rise continues with exercise, an
'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
17-Oct-2003


Page: 1 2

Related biology news :

1. Jefferson Scientists Find Evidence Of Potentially Infectious HIV In Semen, Despite Inability To Detect Active Virus In Blood
2. Researchers discover how worms noses sense oxygen
3. Researchers show absence of key oxygen-sensing molecule leads to developmental defects
4. Ultra-low oxygen could have triggered die-offs, spurred bird breathing system
5. Heart may heal with help from oxygen-sensitive genes, new study suggests
6. Cells ability to live without oxygen give clues for treating major diseases
7. U-Iowa scientists gain insight on how enzyme uses oxygen to produce useful chemicals
8. Topical oxygen helps hard-to-heal wounds heal faster and better
9. Too much oxygen on the cell biology bench? New study suggests so
10. Tibetans retain resistance to the oxygen-deficient disorder hypoxia regardless of altitude
11. Study shows deoxygenating ballast water can prevent invasive species and ship corrosion

Post Your Comments:
(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to inhibit ... development of skin cancers by turning on an enzyme ... cells. , Previously considered protective, SIRT6 is part of ... regulate genomic stability and prevent some of the genetic ... which can lead to cancer. This study, in the ...
(Date:10/14/2014)... October 14, 2014 – High doses of fish oil supplements, ... a common type of irregular heartbeat in which the heart ... results of the AFFORD trial led by the Montreal Heart ... College of Cardiology on October 7th. , For the ... therapy were randomly assigned to 4 grams of fish oil ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... 2014 Research and Markets  has announced ... Material, by Application, Geography - Global Analysis and Forecast ... Organic electronics, also called as polymer electronics ... which deals with small conductive molecules and electrically conductive ... and polymers are carbon based, made using synthetic strategies ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: